ArticleJournal of clinical hypertension (Greenwich, Conn.)2025
Urinary Albumin-to-Creatinine Ratio, Cardiovascular Health, and All-Cause Mortality in Hypertension: A Nationwide Cohort Analysis.
Article in Journal of clinical hypertension (Greenwich, Conn.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
While both cardiovascular health (CVH) and urinary albumin-to-creatinine ratio (UACR) are individually associated with mortality, their combined prognostic significance and potential mechanistic interplay in adults with hypertension remain unclear. This cohort study analyzed data from 9154 hypertensive adults in the National Health and Nutrition Examination Survey 2007-2018. CVH was assessed using the American Heart Association's Life's Essential 8 score, and UACR was measured from spot urine samples. Multivariable Cox proportional hazards models, restricted cubic spline analyses, joint exposure modeling, and causal mediation analysis were used to evaluate the independent, combined, and mediating effects of UACR and CVH on all-cause mortality. Both lower CVH scores and higher UACR levels were independently associated with increased mortality. A nonlinear association was observed for each. Individuals with severely elevated UACR and poor CVH had the highest mortality risk (HR = 6.61; 95% CI, 3.72-11.74), while those with normal UACR (<10 mg/g) showed no significant mortality difference across CVH strata. Notably, even mildly elevated UACR (10-29.9 mg/g), considered within the conventional "normal" range, was associated with significantly increased mortality. Mediation analysis revealed that UACR explained 4.01% (95% CI, 2.83%-6.40%; p < 0.001) of the association between CVH and mortality. This study is the first to demonstrate that UACR not only modifies but also mediates the association between CVH and mortality in individuals with hypertension. These findings underscore the prognostic value of integrating renal and cardiovascular metrics and suggest that even low-grade albuminuria has clinical relevance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.